Latest Articles

Publication Date
Adenomyosis-Associated Differences in Clinicopathological features and Survival Outcomes in endometrial cancer: A meta-analysis - Frontiers

Adenomyosis-Associated Differences in Clinicopathological features and Survival Outcomes in endometrial cancer: A meta-analysis Frontiers

Published: Aug. 4, 2025, 4 p.m.
Impact of the Microcystic, Elongated, and Fragmented (MELF) Invasion Pattern on prognosis in Endometrial Carcinoma: A Comprehensive Meta-Analysis - Frontiers

Impact of the Microcystic, Elongated, and Fragmented (MELF) Invasion Pattern on prognosis in Endometrial Carcinoma: A Comprehensive Meta-Analysis Frontiers

Published: June 3, 2025, 2:36 p.m.
Long-term outcomes in patients with endometrial cancer after sentinel lymph node biopsy versus lymphadenectomy alone: a meta-analysis - Frontiers

Long-term outcomes in patients with endometrial cancer after sentinel lymph node biopsy versus lymphadenectomy alone: a meta-analysis Frontiers

Published: April 28, 2025, 2:35 p.m.
Association between Endometriosis and Gut Microbiota: Systematic Review and Meta-Analysis - Frontiers

Association between Endometriosis and Gut Microbiota: Systematic Review and Meta-Analysis Frontiers

Published: April 7, 2025, 7:49 p.m.
(PDF) Robotic single site versus robotic multiport hysterectomy in endometrial cancer: a systematic review and meta-analysis - ResearchGate

(PDF) Robotic single site versus robotic multiport hysterectomy in endometrial cancer: a systematic review and meta-analysis ResearchGate

Published: March 31, 2025, 4:02 a.m.
Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis - BioMed Central

Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis BioMed Central

Published: Feb. 28, 2025, 10:47 a.m.
Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis - bmcwomenshealth.biomedcentral.com

Efficacy comparison of PD-1/PD-L1 inhibitor monotherapy and combination with PARPis or antiangiogenic agents in advanced or recurrent endometrial cancer: a systematic review and network meta-analysis bmcwomenshealth.biomedcentral.com

Published: Feb. 28, 2025, 10:47 a.m.
Endometriosis and risk of cardiovascular disease: a systematic review and meta-analysis - BMC Public Health

Endometriosis and risk of cardiovascular disease: a systematic review and meta-analysis BMC Public Health

Published: Jan. 21, 2025, 1:41 a.m.
Different surgical methods of hysterectomy for the management of endometrial cancer: A systematic review and network meta-analysis - Frontiers

Different surgical methods of hysterectomy for the management of endometrial cancer: A systematic review and network meta-analysis Frontiers

Published: Dec. 16, 2024, 4:23 p.m.
Meta-analysis of clinicopathologic features of endometrial cancer molecular staging - Frontiers

Meta-analysis of clinicopathologic features of endometrial cancer molecular staging Frontiers

Published: Nov. 28, 2024, 5 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!